ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Alembic Pharma gets USFDA final nod for Desipramine Hydrochloride Tablets USP
July 09, 2021Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Desipramine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg.
Pharma Sources Insight January 2025
